Inspired by record demand for ETFs, many traditional mutual fund providers have recently brought new strategies to the industry. We continue to want to profile some of them.

Consumer spending is slowing and it pushed US GDP into negative territory in Q1. Earnings results continue to be mixed, with Booking Holdings beating expectations last night but Caterpillar missing this morning.

One reason major chip ETFs are saddled with double-digit YTD losses is stocks such as Advanced Micro Devices (AMD) and Nvidia (NVDA) are struggling. Specifically, the Trump administration wants to limit exports on chips produced by U.S.

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Flutter Entertainment (NYSE: FLUT; LSE: FLTR) (“Flutter”) the world's leading online sports betting and iGaming operator today announces that it has completed the acquisition of Snaitech S.p.A. (“Snai”), one of Italy's leading omni-channel operators from a subsidiary of Playtech plc, for cash consideration based on an enterprise value of €2.3b 1 .

As the proliferation of active ETF strategies continues this year, advisors and investors find themselves with an increasing number of choices. Those investors looking to apply the potential benefits of active management to their bond portfolio in a volatile market environment would do well to consider T.

Gold's rally has been evident in the increasing number of mergers and acquisitions in the metal mining industry over the past year. This trend could continue for the foreseeable future, given the strength of gold prices while copper isn't too far behind.

The onset of an aggressive tariff policy, coupled with economic policy uncertainty, led to a rapid decline of expectations for U.S. economic performance in April. In a challenging environment for growth, the American Century U.S. Quality Growth ETF (QGRO) continues to rise above, trimming losses through its blended factor approach to growth investing.

Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo Nordisk. That partnership will see Hims & Hers offer Novo Nordisk's weight-loss drug Wegovy through its platform.

So far, 2025 hasn't exactly been kind to investors. The S&P 500 is down 5.5% year-to-date, weighed down by mounting uncertainty, tariffs, fears of an economic slowdown, and concerns over stretched valuations, particularly in growth-oriented technology stocks.

Vulcan Materials (VMC) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.80 per share a year ago.

Dana (DAN) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.02 per share a year ago.

Garmin (GRMN) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.65 per share. This compares to earnings of $1.42 per share a year ago.

Bausch + Lomb (BLCO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.07 per share a year ago.

Shenandoah Telecommunications (SHEN) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.08 per share a year ago.

Yum Brands (YUM) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.15 per share a year ago.

Oshkosh (OSK) came out with quarterly earnings of $1.92 per share, missing the Zacks Consensus Estimate of $2.02 per share. This compares to earnings of $2.89 per share a year ago.

The Magnificent Seven trade has faltered so far this year. And while the cohort is in recovery mode, I think investors should insist on the better members of the cohort that even Jim Cramer thinks ought to be scrapped.

Earnings for two of the U.S.' handful of trillion-dollar companies will come out Wednesday afternoon as Meta and Microsoft will update investors, kicking off a crucial week for on-edge big technology stocks as tariffs complicated investor appetite for artificial intelligence-driven growth.

U.S.-listed shares of GSK (GSK) are gaining in premarket trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the Trump administration imposes tariffs against the industry.

Norwegian Cruise Line Holdings (NCLH) shares plunged 9% in premarket trading Wednesday, after the company posted earnings that missed analysts' estimates and said it had seen some "softening" in bookings amid economic uncertainty.